发明名称 |
Sustained analgesia achieved with buprenorphine via trans-dermal application |
摘要 |
A method of effectively treating pain in humans is achieved by administering buprenorphine in accordance with first order kinetics over an initial three-day dosing interval, such that a maximum plasma concentration from about 20 pg/ml to about 1052 pg/ml is attained, and thereafter maintaining the administration of buprenorphine for at least an additional two-day dosing interval in accordance with substantially zero order kinetics, such that the patients experience analgesia throughout the at least two-day additional dosing interval. |
申请公布号 |
NZ337386(A) |
申请公布日期 |
2001.06.29 |
申请号 |
NZ19980337386 |
申请日期 |
1998.02.24 |
申请人 |
EURO-CELTIQUE S |
发明人 |
REDER, ROBERT F;GOLDENHEIM, PAUL;KAIKO, ROBERT F |
分类号 |
A61F13/00;A61K9/22;A61K9/70;A61K31/00;A61K31/485;A61P25/00;A61P29/00 |
主分类号 |
A61F13/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|